Jackson, M. L. & Nelson, J. C. The test-negative design for estimating influenza vaccine effectiveness. Vaccine 312165–2168 (2013).
Google Scholar
Chung, J. R. et al. Late-season influenza vaccine effectiveness against medically attended outpatient illness, United States, December 2022–April 2023. Influenza Other Respir. Viruses 18E13342 (2024).
Google Scholar
Trombetta, C. M., Kistner, O., Montomoli, E., Viviani, S. & Marchi, S. Influenza viruses and vaccines: the role of vaccine effectiveness studies for evaluation of the benefits of influenza vaccines. Vaccines (Basel) 10714 (2022).
Google Scholar
McLean, H. Q. et al. Influenza vaccine effectiveness in the United States during 2012–2013: variable protection by age and virus type. J. Infect. Dis. 2111529–1540 (2015).
Google Scholar
Gaglani, M. et al. Influenza vaccine effectiveness against 2009 pandemic influenza A(H1N1) virus differed by vaccine type during 2013–2014 in the United States. J. Infect. Dis. 2131546–1556 (2016).
Google Scholar
Zimmerman, R. K. et al. 2014–2015 influenza vaccine effectiveness in the United States by vaccine type. Clin. Infect. Dis. 631564–1573 (2016).
Google Scholar
Jackson, M. L. et al. Influenza vaccine effectiveness in the United States during the 2015–2016 season. N. Engl. J. Med. 377534–543 (2017).
Google Scholar
Flannery, B. et al. Influenza vaccine effectiveness in the United States during the 2016–2017 season. Clin. Infect. Dis. 681798–1806 (2019).
Google Scholar
Rolfes, M. A. et al. Effects of influenza vaccination in the United States during the 2017–2018 influenza season. Clin. Infect. Dis. 691845–1853 (2019).
Google Scholar
Flannery, B. et al. Spread of antigenically drifted influenza A(H3N2) viruses and vaccine effectiveness in the United States during the 2018–2019 season. J. Infect. Dis. 2218–15 (2019).
Google Scholar
Tenforde, M. W. et al. Effect of antigenic drift on influenza vaccine effectiveness in the United States—2019–2020. Clin. Infect. Dis. 73e4244–e4250 (2020).
Google Scholar
Price, A. M. et al. Influenza vaccine effectiveness against influenza A(H3N2)-related illness in the United States during the 2021–2022 influenza season. Clin. Infect. Dis. 761358–1363 (2022).
Google Scholar
Han, A. X., de Jong, S. P. & Russell, C. A. Co-evolution of immunity and seasonal influenza viruses. Nat. Rev. Microbiol. 21805–817 (2023).
Google Scholar
Lewnard, J. A. & Cobey, S. Immune history and influenza vaccine effectiveness. Vaccines (Basel) 628 (2018).
Google Scholar
Meijers, M. et al. Concepts and methods for predicting viral evolution. In Influenza Virus: Methods and Protocols (eds Yamaauchi, Y. & Amorim, MJ) 253–290 (Just Press, 2025).
Tregoning, J. S., Russell, R. F. & Kinnear, E. Adjuvanted influenza vaccines. Hum. Vaccin. Immunother. 14550–564 (2018).
Google Scholar
Soema, P. C., Kompier, R., Amorij, J.-P. & Kersten, G. F. Current and next generation influenza vaccines: formulation and production strategies. Eur. J. Pharm. Biopharm. 94251–263 (2015).
Google Scholar
DiazGranados, C. A. et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N. Engl. J. Med. 371635–645 (2014).
Google Scholar
Morris, D. H. et al. Predictive modeling of influenza shows the promise of applied evolutionary biology. Trends Microbiol. 26102–118 (2018).
Google Scholar
Shu, Y. & McCauley, J. GISAID: global initiative on sharing all influenza data—from vision to reality. Euro Surveill. 2230494 (2017).
Google Scholar
Hirst, G. K. Studies of antigenic differences among strains of influenza A by means of red cell agglutination. J. Exp. With. 78407–423 (1943).
Google Scholar
Gerdil, C. The annual production cycle for influenza vaccine. Vaccine 211776–1779 (2003).
Google Scholar
Smith, D. J. et al. Mapping the antigenic and genetic evolution of influenza virus. Science 305371–376 (2004).
Google Scholar
Gouma, S., Weirick, M. & Hensley, S. E. Antigenic assessment of the H3N2 component of the 2019–2020 Northern Hemisphere influenza vaccine. Nat. Common. 112445 (2020).
Google Scholar
Barr, I. G. et al. WHO recommendations for the viruses used in the 2013–2014 Northern Hemisphere influenza vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013. Vaccine 324713–4725 (2014).
Google Scholar
Krammer, F. The human antibody response to influenza A virus infection and vaccination. Nat. Rev. Immunol. 19383–397 (2019).
Google Scholar
Gamblin, S. J. & Skehel, J. J. Influenza hemagglutinin and neuraminidase membrane glycoproteins. J. Biol. Chem. 28528403–28409 (2010).
Google Scholar
Bush, R. M., Bender, C. A., Subbarao, K., Cox, N. J. & Fitch, W. M. Predicting the evolution of human influenza A. Science 2861921–1925 (1999).
Google Scholar
Gupta, V., Earl, D. J. & Deem, M. W. Quantifying influenza vaccine efficacy and antigenic distance. Vaccine 243881–3888 (2006).
Google Scholar
Steinbrück, L. & McHardy, A. C. Allele dynamics plots for the study of evolutionary dynamics in viral populations. Nucleic Acids Res. 39E4 (2011).
Google Scholar
Neher, R. A., Russell, C. A. & Shraiman, B. I. Predicting evolution from the shape of genealogical trees. eLife 3e03568 (2014).
Google Scholar
Łuksza, M. & Lässig, M. A predictive fitness model for influenza. Nature 50757–61 (2014).
Google Scholar
Obermeyer, F. et al. Analysis of 6.4 million SARS-CoV-2 genomes identifies mutations associated with fitness. Science 3761327–1332 (2022).
Google Scholar
Doud, M. B., Lee, J. M. & Bloom, J. D. How single mutations affect viral escape from broad and narrow antibodies to H1 influenza hemagglutinin. Nat. Common. 91386 (2018).
Google Scholar
Huddleston, J. et al. Integrating genotypes and phenotypes improves long-term forecasts of seasonal influenza A/H3N2 evolution. eLife 9e60067 (2020).
Google Scholar
Steinbrück, L., Klingen, T. & McHardy, A. Computational prediction of vaccine strains for human influenza A (H3N2) viruses. J. Virol. 8812123–12132 (2014).
Google Scholar
Suzuki, Y. Selecting vaccine strains for H3N2 human influenza A virus. Meta Gene 464–72 (2015).
Google Scholar
Gong, L. I., Suchard, M. A. & Bloom, J. D. Stability-mediated epistasis constrains the evolution of an influenza protein. eLife 2e00631 (2013).
Google Scholar
Hie, B., Zhong, E. D., Berger, B. & Bryson, B. Learning the language of viral evolution and escape. Science 371284–288 (2021).
Google Scholar
Ferruz, N., Schmidt, S. & Höcker, B. ProtGPT2 is a deep unsupervised language model for protein design. Nat. Common. 134348 (2022).
Google Scholar
Frazer, J. et al. Disease variant prediction with deep generative models of evolutionary data. Nature 59991–95 (2021).
Google Scholar
Thadani, N. N. et al. Learning from prepandemic data to forecast viral escape. Nature 622818–825 (2023).
Google Scholar
Han, W. et al. Predicting the antigenic evolution of SARS-COV-2 with deep learning. Nat. Common. 143478 (2023).
Google Scholar
Radford, A. et al. Language models are unsupervised multitask learners. Openai https://cdn.openai.com/better-language-models/language_models_are_unsupervised_multitask_learners.pdf (2019).
Rao, R. M. et al. MSA Transformer. In Proc. of the 38th International Conference on Machine Learning 8844–8856 (PMLR, 2021).
Kostova, D. et al. Influenza illness and hospitalizations averted by influenza vaccination in the United States, 2005–2011. PLoS ONE 8e66312 (2013).
Google Scholar
Tokars, J. I., Rolfes, M. A., Foppa, I. M. & Reed, C. An evaluation and update of methods for estimating the number of influenza cases averted by vaccination in the United States. Vaccine 367331–7337 (2018).
Google Scholar
Price, A. M. et al. Influenza vaccine effectiveness against influenza A(H3N2)-related illness in the United States during the 2021–2022 influenza season. Clin. Infect. Dis. 761358–1363 (2023).
Google Scholar
Doll, M. K., Pettigrew, S. M., Ma, J. & Verma, A. Effects of confounding bias in coronavirus disease 2019 (COVID-19) and influenza vaccine effectiveness test-negative designs due to correlated influenza and COVID-19 vaccination behaviors. Clin. Infect. Dis. 75e564–e571 (2022).
Google Scholar
Kissling, E. et al. I-MOVE multicentre case–control study 2010/11 to 2014/15: is there within-season waning of influenza type/subtype vaccine effectiveness with increasing time since vaccination? Euro Surveill. 2130201 (2016).
Google Scholar
Kissling, E. et al. 2015/16 I-MOVE/I-MOVE+ multicentre case-control study in Europe: moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage-mismatched influenza B among children. Influenza Other Respir. Viruses 12423–437 (2018).
Google Scholar
Kissling, E. et al. Effectiveness of influenza vaccine against influenza A in Europe in seasons of different A(H1N1)pdm09 and the same A(H3N2) vaccine components (2016–17 and 2017–18). Vaccine X 3100042 (2019).
Google Scholar
Kissling, E. et al. Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019. Euro Surveill. 241900121 (2019).
Google Scholar
Rose, A. et al. Interim 2019/20 influenza vaccine effectiveness: six European studies, September 2019 to January 2020. Euro Surveill. 252000153 (2020).
Google Scholar
Kissling, E. et al. Influenza vaccine effectiveness against influenza A subtypes in Europe: results from the 2021–2022 I-MOVE primary care multicentre study. Influenza Other Respir. Viruses 17e13069 (2023).
Google Scholar
Skowronski, D. et al. Interim estimates of influenza vaccine effectiveness in 2012/13 from Canada’s sentinel surveillance network, January 2013. Euro Surveill. 1820394 (2013).
Google Scholar
Skowronski, D. et al. Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada’s sentinel surveillance network, January 2014. Euro Surveill. 1920690 (2014).
Skowronski, D. et al. Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada’s sentinel physician surveillance network, January 2015. Euro Surveill. 2021022 (2015).
Google Scholar
Chambers, C. et al. Interim estimates of 2015/16 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, February 2016. Euro Surveill. 2130168 (2016).
Google Scholar
Skowronski, D. M. et al. Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017. Euro Surveill. 2230460 (2017).
Google Scholar
Skowronski, D. M. et al. Early season co-circulation of influenza A(H3N2) and B (Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018. Euro Surveill. 2318–00035 (2018).
Google Scholar
Skowronski, D. M. et al. Interim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019. Euro Surveill. 241900055 (2019).
Google Scholar
Skowronski, D. M. et al. Interim estimates of 2019/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020. Euro Surveill. 252000103 (2020).
Google Scholar
Reed, C. et al. Estimating influenza disease burden from population-based surveillance data in the United States. PLoS ONE 10e0118369 (2015).
Google Scholar
Palache, A. et al. Influenza vaccines: the effect of vaccine dose on antibody response in primed populations during the ongoing interpandemic period. A review of the literature. Vaccine 11892–908 (1993).
Google Scholar
Gambaryan, A., Robertson, J. & Matrosovich, M. Effects of egg-adaptation on the receptor-binding properties of human influenza A and B viruses. Virology 258232–239 (1999).
Google Scholar
Mylius, SD, Hagenars, TJ, Lugnér, AK & Walllinga, J. Optica allocation or pandmic influenza vaccines vaccine deeply, risks, and timing. Vaccine 263742–3749 (2008).
Google Scholar
Skowronski, D. M. et al. Low 2012–13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses. PLoS ONE 9E92153 (2014).
Google Scholar
Van Baalen, C. et al. Detection of nonhemagglutinating influenza A(H3) viruses by enzyme-linked immunosorbent assay in quantitative influenza virus culture. J. Clin. Microbiol. 521672–1677 (2014).
Google Scholar
Fonville, J. M. et al. Antigenic maps of influenza A(H3N2) produced with human antisera obtained after primary infection. J. Infect. Dis. 21331–38 (2016).
Google Scholar
Zost, S. J. et al. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains. Proc. Natl Acad. Sci. USA 11412578–12583 (2017).
Google Scholar
WHO Global Influenza Surveillance Network. Manual for the laboratory diagnosis and virological surveillance of influenza. https://www.who.int/publications/i/item/manual-for-the-laboratory-diagnosis-and-virological-surveillance-of-influenza (World Health Organization, 2011).
Jorquera, P. A. et al. Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011–2018. Sci. Rep. 92676 (2019).
Google Scholar
Peck, H. et al. Enhanced isolation of influenza viruses in qualified cells improves the probability of well-matched vaccines. NPJ Vaccines 6149 (2021).
Google Scholar
Matrosovich, M. N., Matrosovich, T. Y., Gray, T., Roberts, N. A. & Klenk, H.-D. Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium. J. Virol. 7812665–12667 (2004).
Google Scholar
Sylte, M. J. & Suarez, D. L. Influenza neuraminidase as a vaccine antigen. In Vaccines for Pandemic Influenza (eds Compans, R. W. & Orenstein, W. A.) 227–242 (Springer, 2009).
Monto, A. S. et al. Antibody to influenza virus neuraminidase: an independent correlate of protection. J. Infect. Dis. 2121191–1199 (2015).
Google Scholar
Neher, R. A. & Bedford, T. nextflu: real-time tracking of seasonal influenza virus evolution in humans. Bioinformatics 313546–3548 (2015).
Google Scholar
Steinegger, M. & Söding, J. MMseqs2 enables sensitive protein sequence searching for the analysis of massive data sets. Nat. Biotechnol. 351026–1028 (2017).
Google Scholar
Neher, R. A., Bedford, T., Daniels, R. S., Russell, C. A. & Shraiman, B. I. Prediction, dynamics, and visualization of antigenic phenotypes of seasonal influenza viruses. Proc. Natl Acad. Sci. USA 113E1701–E1709 (2016).
Google Scholar
Kermack, W. O. & McKendrick, A. G. A contribution to the mathematical theory of epidemics. Proc. R. Soc. Lond. Ser. A 115700–721 (1927).
Google Scholar
Henikoff, S. & Henikoff, J. G. Amino acid substitution matrices from protein blocks. Proc. Natl Acad. Sci. USA 8910915–10919 (1992).
Google Scholar
Xia, Y.-L. et al. A deep learning approach for predicting antigenic variation of influenza A H3N2. Comput. Math. Methods Med. 20219997669 (2021).
Schober, P., Boer, C. & Schwarte, La Correlation Coefficents: Appropriates Use and Interpretation. Anesth. Analg. 1261763–1768 (2018).
Google Scholar
Centers for Disease Control and Prevention. Influenza Hospitalization Surveillance Network (FluSurv-NET). https://www.cdc.gov/fluview/overview/influenza-hospitalization-surveillance.html (2023).
Aksamentov, I., Roemer, C., Hodcroft, E. B. & Neher, R. A. Nextclade: clade assignment, mutation calling and quality control for viral genomes. J. Open Source Softw. 63773 (2021).
Google Scholar
Kim, S. et al. Influenza vaccine effectiveness against A(H3N2) during the delayed 2021/22 epidemic in Canada. Euro Surveill. 272200720 (2022).
Google Scholar
